Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.
AOL

Will an mRNA Flu Vaccine Offer Better Protection?

The U.S. Food and Drug Administration (FDA) is reviewing a new flu vaccine for adults age 50 and older. If approved, it would be the first influenza shot to use mRNA technology, and experts say it ...

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to ...